The fundamental purpose of Yu Ting is to address the acute risk of unintended conception, generally serving as an option within the category of emergency contraception (EC). This medication is used for managing the risk of unplanned conception following unprotected intercourse or a known or suspected contraceptive failure. It is explicitly not a method for routine birth control but is considered relevant in acute reproductive health scenarios.

Acute Management of Unplanned Conception Risk

Yu Ting is used as an intervention relevant for clinical settings that involve acute or unstable symptom patterns to address the acute risk of unintended conception that follows unprotected sexual intercourse or a recognized lapse in primary contraception. This medicine is applied in circumstances where short-term assistance is appropriate, and may assist with addressing acute exposure in reproductive planning.

Support for Reproductive Health Autonomy

A key benefit of Yu Ting is its role in supporting a patient's autonomy and decision-making by assisting with addressing uncertainty regarding acute exposure risk. It supports the patient during difficult episodes by easing the distress associated with potential unplanned pregnancy, which helps patients cope more steadily with challenging and unforeseen circumstances.

---

Quick Fact: Supportive management of post-event distress The primary benefit is assisting with addressing the acute risk of conception, which provides additional support in easing the distress and uncertainty associated with unexpected exposure.

The eligibility for Yu Ting (Levonorgestrel) is strictly defined by regulatory agencies and focuses on women of reproductive potential. The medicine is approved for females of childbearing potential, including adolescents who have reached menarche.

Eligibility Status	Population or Condition
Contraindicated	Known or suspected pregnancy or hypersensitivity to the active ingredient or excipients.
Contraindicated	Hereditary conditions such as lactose intolerance (due to product excipients).
Not Recommended	Women with severe hepatic dysfunction (severe liver impairment).
Conditional Use	History of ectopic pregnancy or previous salpingitis.

Use is not indicated for premenarcheal children or postmenopausal women, as the emergency contraceptive purpose is not relevant for these age groups. During lactation, the medicine is excreted in breast milk, and official guidance advises minimizing infant exposure by avoiding nursing for eight hours after taking the dose. Caution is also required for women with severe malabsorption syndromes or those taking certain hepatic enzyme-inducing drugs, which can affect the required regimen.

The regulatory profile for Yu Ting (Levonorgestrel) is defined by pharmacokinetic interactions that significantly reduce the medicine's plasma concentration, classifying this as a clinically significant interaction. No specific drug-drug combination is formally listed as contraindicated in the official regulatory labeling.

---

Interaction Scope: Enzyme Induction and Decreased Effectiveness

The primary interaction mechanism is enzyme induction involving CYP3A4 enzymes. Drugs or herbal products that induce these liver enzymes increase the metabolic rate and clearance of levonorgestrel. This results in decreased plasma concentrations of the progestin, which compromises the effectiveness of the emergency contraceptive.

---

Officially Listed Interacting Medicines

Regulatory documents explicitly list agents known to decrease Levonorgestrel exposure. These include:

• Anticonvulsants: Phenytoin, Carbamazepine, Topiramate, and Primidone.
• Anti-infectives: Rifampin and Griseofulvin.
• Herbal Product: St. John's wort (Hypericum perforatum).

Furthermore, significant and variable changes in plasma levels (both increases and decreases) have been noted with co-administration of HIV protease inhibitors or non-nucleoside reverse transcriptase inhibitors (e.g., Efavirenz). The enzyme-inducing effect that reduces effectiveness may persist for up to four weeks after cessation of the interacting product.

Yu Ting functions primarily as a highly specific non-steroidal antagonist of the Glucocorticoid Receptor (GR), a member of the nuclear receptor superfamily. It achieves this by binding directly to the GR ligand-binding domain. This interaction physically prevents endogenous glucocorticoids, such as cortisol, from initiating the canonical receptor signaling pathway, thereby inhibiting receptor dimerization and subsequent nuclear translocation.

The blockade of the GR complex directly modulates gene expression by preventing the binding of the activated GR dimer to Glucocorticoid Response Elements (GREs) within the promoter regions of target genes. This selective inhibition leads to the decreased transcription of inflammatory mediators, including various cytokines and chemokines. Concurrently, it influences the activity of key transcription factors, notably inhibiting NF-kappa B signaling by preventing interaction with the GR, leading to a downstream reduction in pro-inflammatory protein synthesis.

At the systemic level, this targeted receptor antagonism results in the precise re-establishment of normal hypothalamic-pituitary-adrenal (HPA) axis feedback loops that may be dysregulated in certain physiological states. By competitively blocking GR activity, Yu Ting selectively attenuates the excessive or aberrant activation of these endocrine feedback mechanisms, contributing to a shift in the overall physiological steady-state related to stress and metabolic regulation.

How to Use Yu Ting: Administration Guidelines

Yu Ting (Levonorgestrel) is a synthetic hormonal medication for single-event emergency contraception and is not for use as a form of routine birth control. Its administration follows specific timing and dosing protocols.

---

Administration Scope

Category	Official Administration Instruction
Route of Administration	The treatment is administered through oral ingestion of the tablet.
Standard Dosing Schedule	The standard regimen is a single, 1.5 mg tablet taken at once. An alternative regimen consists of two 0.75 mg tablets, with the second dose taken 12 hours after the first.
Time-Critical Window	The dose must be taken as soon as possible, preferably within 12 hours, but no later than 72 hours (3 days) following the unprotected sexual event.
Timing in Relation to Meals	Administration is independent of food.

---

Procedural and Population-Specific Conditions

Specific conditions apply to the handling of administration issues and use in different populations. If vomiting occurs within three hours of taking the tablet, a repeat dose is required to ensure the required dosage is absorbed. The product is appropriate for post-menarcheal adolescents and is taken regardless of the user's body weight or Body Mass Index (BMI). For individuals taking certain hepatic enzyme-inducing drugs, a specialized 3 mg total dose (two 1.5 mg tablets taken together) is used if a non-hormonal option is unavailable. The medication is designed for single-event use and is not to be repeatedly administered within a single menstrual cycle.

Research Evidence / Overview of Studies for Yu Ting (Levonorgestrel)

---

Evidence for Use in Acute Risk of Unintended Conception

Research exploring the use of Levonorgestrel in this context focuses on examining the outcome of pregnancy risk following unprotected sexual intercourse or a recognized lapse in primary contraception. Studies conducted to evaluate this medicine include large-scale Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that consolidate data from multiple investigations. These trials were designed to examine outcomes related to the acute risk of conception in women of child-bearing potential.

Analyses described patterns observed in the studies, including the relationship between the timing of administration and the observed pregnancy rate. Research described that the observed pregnancy rate varied inversely with the time elapsed between the event and treatment. The evidence level for this line of research is broadly considered High.

---

Types of Studies and Outcomes Examined

Comparative studies have been conducted to evaluate Levonorgestrel alongside other regimens of emergency contraception. These trials measured the observed pregnancy rates for the regimens being compared under the study conditions.

Pharmacodynamic studies also form a key part of the evidence. These trials monitored physiological strain related to hormonal levels and follicular development in observed populations. These studies monitored outcomes related to physical discomfort or systemic imbalance.

---

Research in Specific Groups and Uncertainties

Research has focused on women with different Body Mass Index (BMI) or body weight categories. Pooled trial data analyses have described mixed findings related to outcomes in women with higher body weight/BMI. While some studies suggested that findings were less consistent in these groups, other reviews described the available data as inconclusive.

A key research limitation is the time-dependency observed in the studies. Furthermore, the evidence for later time points, such as between 96 and 120 hours, is more limited than the data available for the shorter interval of 72 hours. Data for the effects of frequent or repeated use of Levonorgestrel are scarce or of low certainty in systematic reviews.

Common questions about Yu Ting (FAQ)

---

Q: What is the estimated failure rate or effectiveness of Yu Ting?

Official studies indicate that this medicine is effective at reducing the risk of pregnancy when used within the specified time window. The observed pregnancy rate in clinical studies has been reported as low, typically less than 2%, when used within the first 72 hours after unprotected intercourse. This rate is significantly lower than the expected rate if no emergency contraceptive were used.

---

Q: Can I use Yu Ting as a regular method of birth control?

No, according to official product information, Yu Ting is not intended for routine use as a regular birth control method. It is specifically indicated only as an emergency measure for postcoital contraception. Official information indicates it is less effective than conventional, consistent methods of ongoing contraception.

---

Q: What is the best way to safely dispose of unused or expired pills?

To prevent accidental exposure or environmental contamination, unused or expired medicine should not be flushed down a toilet or placed in the household trash. Government guidelines recommend using formal community drug take-back programs for safe disposal. If a take-back program is unavailable, general guidance suggests mixing the medicine with an undesirable substance, such as coffee grounds, sealing the mixture, and placing it in the trash.

---

Q: If I become pregnant after taking Yu Ting, what are the risks to the baby or the pregnancy?

Official labeling states the medicine is contraindicated (should not be used) if pregnancy is known or suspected because it is not effective at ending a pregnancy. While data on fetal harm from emergency contraceptive doses are limited, official documents emphasize that the possibility of an ectopic pregnancy (where the pregnancy develops outside the uterus) must be ruled out if pregnancy occurs or if severe abdominal pain develops.

---

Q: What should I do if my menstrual period is severely delayed after taking Yu Ting?

Temporary changes to the menstrual cycle, including a delay, are commonly reported side effects. However, official safety precautions state that if your menstrual period is delayed by more than one week (7 days) after taking the medicine, it is recommended that you consult a healthcare professional to rule out the possibility of pregnancy.

How to Store and Dispose of Yu Ting?

Because product-specific labeling for Yu Ting is not available, official storage and disposal must adhere to universal Good Storage Practices (GSP) and regulatory waste standards.

Storage Requirements

All medicines must be stored strictly according to the temperature and environmental limits established by stability testing, typically requiring a clean, dry environment protected from direct light and excessive moisture. To maintain quality, the product must be kept in its original container and used only until the official expiry date. Stock must be rotated following the First Expired/First Out (FEFO) principle.

Disposal Instructions

Do not dispose of expired or unused medicine in the household trash or by flushing it down a toilet, unless a regulatory agency, such as the FDA, specifically authorizes it. Disposal must be handled through official channels, such as community drug take-back programs, to prevent environmental contamination and accidental exposure. Controlled or high-risk substances must be secured in a locked area and disposed of according to strict governmental hazardous-waste protocols.